Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 939-941, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arrer, E.
Right arrow Articles by Patsch, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arrer, E.
Right arrow Articles by Patsch, W.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2002;48:939-941.)
© 2002 American Association for Clinical Chemistry, Inc.


Technical Briefs

ß-Trace Protein as a Marker for Cerebrospinal Fluid Rhinorrhea

Erich Arrer1a, Cem Meco2, Gerhard Oberascher2, Wolfgang Piotrowski3, Klaus Albegger2 and Wolfgang Patsch1

1 Department of Laboratory Medicine,
2 Ear, Nose, and Throat Department, and
3 Department of Neurosurgery, Landeskliniken Salzburg, Müllner Hauptstrasse 48, A-5020 Salzburg, Austria

aauthor for correspondence: fax 43-662-4482-885, e-mail e.arrer@lks.at

Cerebrospinal fluid (CSF) leakage occurs mainly as a complication of head injuries or skull-base surgeries, but may also occur spontaneously or as a result of nontraumatic processes such as inflammatory disorders or tumors (1). Detection and management of CSF leakage is essential to prevent possible life-threatening infections of the central nervous system (2). Radiologic and invasive procedures may be used for the diagnosis of CSF leaks, but these procedures are laborious, expensive, and present potential risk to the patient. Therefore, noninvasive laboratory methods serve as screening procedures before definitive procedures are used to localize the site of the defect.

Laboratory assessment of CSF leakage relies on compositional differences between CSF and other body secretions. The ß2-transferrin (ß2Tr) {tau}-fraction, or asialotransferrin, is a brain-specific variant of transferrin that lacks neuraminic acid. It therefore can be distinguished from serum transferrin by electrophoretic procedures and used to detect CSF rhinorrhea (3)(4). However, ß2Tr is present in aqueous humor and in perilymph fluid and can be detected in serum, especially in chronic alcohol abusers and in patients with inborn errors of glycoprotein metabolism or genetic variants of transferrin (5)(6).

ß-Trace protein (ßTP), recently identified as prostaglandin D2 synthase (7), is another brain-specific protein that is produced mainly in the leptomeninges and the choroid plexus and is secreted into the CSF. ßTP is the second most abundant protein in CSF after albumin. However, it is also present in other body fluids, including serum, albeit at much lower concentrations than in CSF (8). Immunoelectrophoretic methods for ßTP have been applied as a screening procedure for CSF leaks (9)(10). Recently, a nephelometric assay for the quantification of ßTP was introduced that promised several advantages over current . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
RadiologyHome page
K. M. Lloyd, J. M. DelGaudio, and P. A. Hudgins
Imaging of Skull Base Cerebrospinal Fluid Leaks in Adults
Radiology, September 1, 2008; 248(3): 725 - 736.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Gorogh, P. Rudolph, J. E. Meyer, J. A. Werner, B. M. Lippert, and S. Maune
Separation of {beta}2-Transferrin by Denaturing Gel Electrophoresis to Detect Cerebrospinal Fluid in Ear and Nasal Fluids
Clin. Chem., September 1, 2005; 51(9): 1704 - 1710.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. L. Sanders, R. J. Clark, and J. A. Katzmann
Cerebrospinal Fluid Leakage: Agarose Gel Electrophoresis Detection of {beta}2-Transferrin and Nephelometric Quantification of {beta}-Trace Protein
Clin. Chem., December 1, 2004; 50(12): 2401 - 2403.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Schnabel, E. Di Martino, J. M. Gilsbach, D. Riediger, A. M. Gressner, and D. Kunz
Comparison of {beta}2-Transferrin and {beta}-Trace Protein for Detection of Cerebrospinal Fluid in Nasal and Ear Fluids
Clin. Chem., March 1, 2004; 50(3): 661 - 663.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.